These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen. Woodhouse KW; Hamilton P; Lennard A; Rawlins MD Eur J Clin Pharmacol; 1983; 24(2):283-5. PubMed ID: 6840181 [TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. Bosanquet AG; Gilby ED Eur J Cancer Clin Oncol; 1982 Apr; 18(4):355-62. PubMed ID: 6889512 [TBL] [Abstract][Full Text] [Related]
46. Pharmacology of intravenous melphalan in patients with multiple myeloma. Brox L; Birkett L; Belch A Cancer Treat Rev; 1979 Jun; 6 Suppl():27-32. PubMed ID: 498169 [No Abstract] [Full Text] [Related]
47. Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma. Gera S; Musch E; Osterheld HK; Loos U Cancer Chemother Pharmacol; 1989; 23(2):76-80. PubMed ID: 2910515 [TBL] [Abstract][Full Text] [Related]
48. High-dose intravenous melphalan in a patient with multiple myeloma and oliguric renal failure. Pecherstorfer M; Zimmer-Roth I; Weidinger S; Irsigler K; Halbmayer WM; Ulrich W; Fischer M; Baumgartner G Clin Investig; 1994 Jul; 72(7):522-5. PubMed ID: 7981581 [TBL] [Abstract][Full Text] [Related]
49. Oral complications of high-dose melphalan in multiple myeloma. Barrett AP; Buckley DJ Oral Surg Oral Med Oral Pathol; 1987 Aug; 64(2):264-7. PubMed ID: 3476906 [TBL] [Abstract][Full Text] [Related]
57. Leukemia on myeloma. Quirt IC; Hart GD; Soots M Br Med J; 1972 Jan; 1(5794):248. PubMed ID: 4500986 [No Abstract] [Full Text] [Related]
58. Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma. Bosanquet AG; Gilby ED Cancer Chemother Pharmacol; 1984; 12(3):183-6. PubMed ID: 6705135 [TBL] [Abstract][Full Text] [Related]